About Jerre Stead
Jerre Stead is a director at Spinogenix.
Form D filings also name Jerre Stead as a director at Amydis.
Jerre Stead first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jerre Stead in the role, so the role may have started earlier or lasted longer.
Spinogenix, Inc.
Director
2024 – 2026 · Los Angeles, CA
Develops experimental medicines for people with neurological and psychiatric conditions.
Key Colleagues at Startups
The people Jerre Stead works with at each company, as listed on that company's latest Form D.
Spinogenix, Inc. · Form D, Mar 9, 2026
Amydis, Inc. · Form D, Dec 28, 2023
CA
Christine Aylward
Director
MT
Mervyn Turner
Director
SS
Stella Sarraf
CEO and director
JK
James Khodabakhsh
Director
JC
Jack Thrift, CPA
Executive officer